FMP
Dec 08, 2025
IMAX Corporation (NYSE:IMAX) is a leading entertainment technology company known for its large-format theaters and immersive cinematic experiences. The company operates globally, providing advanced projection systems and high-quality content to moviegoers. IMAX competes with other cinema technology providers and content distributors, striving to maintain its position as a top choice for premium movie experiences.
On December 8, 2025, Eric Handler from Roth Capital set a price target of $42 for IMAX. At that time, the stock was trading at $38.31, suggesting a potential upside of approximately 9.63%. This optimistic outlook aligns with IMAX's strong momentum rating, as highlighted by Zacks Investment Research, which positions the stock as a top momentum pick for long-term investment.
Zacks Investment Research emphasizes the importance of the Zacks Style Scores, which rate stocks based on value, growth, and momentum. These scores complement the Zacks Rank, helping investors identify stocks with high potential to outperform the market. IMAX's strong momentum rating suggests it is well-positioned to deliver market-beating returns, making it an attractive option for investors.
Currently, IMAX is trading at $38.40, reflecting a significant increase of approximately 7.52% with a rise of $2.69. The stock has fluctuated between a low of $36.30 and a high of $38.49 today, with the latter marking its highest price over the past year. This performance indicates strong investor interest and confidence in the company's future prospects.
IMAX's market capitalization stands at approximately $2.07 billion, with a trading volume of 702,457 shares. This substantial market cap and active trading volume highlight the company's prominence in the entertainment technology sector and its appeal to investors seeking growth opportunities.
Antero Resources Corporation (NYSE: AR) is a prominent player in the energy sector, primarily engaged in the exploration...
Amgen Inc. (NASDAQ: AMGN) is a leading biotechnology company known for its innovative therapies and treatments. The comp...